Study shows how resistance to chemotherapies may occur in some cancers

25

New Delhi, March 29 (IANS) US researchers have found how resistance to chemotherapies may occur in some cancers, an advance that could help pinpoint treatment-resistant tumours.

Chemotherapy resistance is a major challenge in cancer treatment. It occurs when cancer cells stop responding to chemotherapy, allowing the tumour to grow again.

The team from Mass General Brigham focused on a pathway that harnesses reactive oxygen species (ROS) to kill cancer cells. The study, published in the journal Nature, found that mutations to VPS35 — a key player in this pathway — can prevent chemotherapy-induced cell death.

“ROS play an important role in healthy and diseased cells, but pathways that sense and control cellular ROS levels are not well understood,” said corresponding author Liron Bar-Peled, of the Krantz Family Center for Cancer Research at the hospital.

“A clearer understanding of ROS could help us understand why chemoresistance occurs in some cases.”

Low concentrations of ROS are required for normal cell signalling, but higher levels of ROS can damage cells and contribute to diseases such as cancer and neurodegeneration.

Previous studies have shown that mitochondria play an important role in ROS production, but it has been unclear if ROS-sensing proteins influence the mitochondria. If they do, this could impact responses to some anti-cancer treatments.

To investigate the team screened cancer cells for ROS-sensing proteins that might contribute to chemoresistance.

They identified mutations that increased treatment resistance, and the team traced two of them to a protein called VPS35. Further studies showed that these mutations led to lowered ROS levels within the cell.

In addition, they analysed VPS35 expression levels in 24 patients with high-grade serous ovarian cancer (HGSOC), who received treatment at MGCC. They noted that higher tumoral VPS35 levels were associated with improved treatment responses and overall survival rates.

–IANS

rvt/

Go to Source

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

MGID